ICMR allows 21 institutions to participating in clinical trials with plasma to contain COVID-19

The Indian Council of Medical Research (ICMR) has approved 21 institutions for conducting plasma therapy to limit complications associated with COVID-19.

The therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those antibodies into an active coronavirus patient.

Currently, the ICMR does not recommend this as a treatment option outside of clinical trials.


Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea